Organovo trading halted, news pending
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Mar 20 2025
0mins
Source: Business Insider
Trading Halt: Organovo (ONVO) has had its trading halted due to pending news, indicating potential significant developments for the company.
Corporate Actions: The company announced a 1-for-12 reverse stock split and is set to be acquired by Eli Lilly, which will expand Eli Lilly's IBD pipeline with Organovo’s FXR program.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
